Skip to content

Influence of Obesity and Gastric Bypass on Medication Absorption

Influence of Obesity and Gastric Bypass on Medication Absorption: Prospective Follow-up of Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01571180
Acronym
INOGMA
Enrollment
100
Registered
2012-04-05
Start date
2012-04-30
Completion date
2017-09-30
Last updated
2017-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Obesity, Gastric bypass, Medication, Medication counseling, Dietary pattern, Follow-up of patients

Brief summary

Patients who have scheduled a gastric bypass (RYGB) in UZ Leuven, will be questioned preoperatively and one, three, six and twelve months after gastric bypass surgery. The purpose of this study is to explore current practice regarding the use of medication and medication counseling after RYGB and to examine the changes in dietary pattern before and after RYGB.

Detailed description

Target group: patients who have scheduled a gastric bypass in UZ Leuven. Patients will be questioned preoperatively and one, three, six and twelve months after gastric bypass surgery. Each assessment will be performed during a routine consultation. The following aspects will be investigated: * Medication The investigators have composed a questionnaire to examine which drugs the patients use, adherence, information received about medication and from whom,… * Clinical parameters Every consultation, concentrations of hemoglobin, iron, hepcidin, vitamin B12,…. and a 24h urine collection to determine calcium excretion will be collected. * Dietary intake The investigators will ask patients to keep a food record during two non-consecutive days preceding each consultation. In this food record patients have to note all consumed foods and beverages with the right/estimated amounts. This makes it possible to see the changes of the composition of the meals before and after RYGB. * Body composition

Interventions

None listed

Sponsors

KU Leuven
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who have scheduled gastric bypass * Use of at least one chronic drug (including contraception)

Exclusion criteria

* Patients who have undergone another form of bariatric surgery before RYGB

Design outcomes

Primary

MeasureTime frameDescription
Medication useone yearPatients will be questioned preoperatively and one, three, six and twelve months after gastric bypass surgery. A questionnaire will be used to examine which drugs patients use and to what level they are adherent to treatment recommendations.

Secondary

MeasureTime frameDescription
Changes in dietary pattern before and after RYGBone yearThe investigators will ask patients to keep a food record during two non-consecutive days preceding each consultation. In this food record patients have to note all consumed foods and beverages with the right/estimated amounts. This makes it possible to see changes of the composition of the meals before and after RYGB. The correlation between the dietary/total intake and clinical parameters will be investigated.
Medication counselingone yearPatients will be questioned preoperatively and one, three, six and twelve months after gastric bypass surgery. A questionnaire will be used to examine what kind of information they received about medication use pre- and post-RYGB.

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026